Trial Profile
Botulinum toxin A administered as doses of 50, 100, 150, 200 or 300U in patients with overactive bladder and urge urinary incontinence
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Sep 2012
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Overactive bladder; Urge incontinence
- Focus Therapeutic Use
- 01 Aug 2012 Results published in the International Urogynecology Journal.
- 01 Apr 2011 Results published in Neurourology and Urodynamics.
- 05 Nov 2010 New trial record.